CNS Pharmaceuticals, Inc. Stock-Based Compensation
CNS Pharmaceuticals, Inc. (CNSP) reported Stock-Based Compensation of $2.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-12
- CNS Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.00K, a 90.91% decline year-over-year.
- CNS Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.56K, a 95.90% decline year-over-year.
- CNS Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $85.07K, a 34.51% decline year-over-year.
- CNS Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $18.66K, a 93.13% decline year-over-year.
- CNS Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $187.73K, a 77.62% decline from fiscal 2024.
- CNS Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $838.96K, a 16.72% decline from fiscal 2023.
- CNS Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $1.01M, a 16.26% decline from fiscal 2022.
- CNS Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $1.20M, a 30.22% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-12 | $5.00K 10-Q · filed 2026-08-12 | $89.62K derived: sum of 3 quarters · filed 2026-08-12 | $108.28K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $2.56K 10-Q · filed 2026-05-14 | $87.62K derived: sum of 2 quarters · filed 2026-05-14 | $106.28K derived: sum of 3 quarters · filed 2026-05-14 | $128.28K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $85.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $103.73K derived: sum of 2 quarters · filed 2026-03-31 | $125.73K derived: sum of 3 quarters · filed 2026-08-12 | $187.73K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $18.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $40.66K derived: sum of 2 quarters · filed 2026-08-12 | $102.66K 10-Q · filed 2025-11-14 | $232.93K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $22.00K 10-Q · filed 2026-08-12 | $84.00K 10-Q · filed 2026-08-12 | $84.21K 10-Q · filed 2025-08-14 | $214.27K derived: sum of 3 quarters · filed 2026-08-12 | $486.05K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $62.37K 10-Q · filed 2026-05-14 | $192.27K derived: sum of 2 quarters · filed 2026-05-14 | $464.05K derived: sum of 3 quarters · filed 2026-05-14 | $698.39K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $129.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $401.68K derived: sum of 2 quarters · filed 2026-03-31 | $636.02K derived: sum of 3 quarters · filed 2026-03-31 | $838.96K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $271.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $506.12K derived: sum of 2 quarters · filed 2025-11-14 | $709.06K 10-Q · filed 2025-11-14 | $941.73K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $234.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $437.28K 10-Q · filed 2025-08-14 | $669.95K derived: sum of 3 quarters · filed 2025-08-14 | $864.71K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $202.93K 10-Q · filed 2025-05-15 | $435.61K derived: sum of 2 quarters · filed 2025-05-15 | $630.37K derived: sum of 3 quarters · filed 2025-05-15 | $920.04K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $232.68K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $427.43K derived: sum of 2 quarters · filed 2025-03-31 | $717.10K derived: sum of 3 quarters · filed 2025-03-31 | $1.01M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $194.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $484.43K derived: sum of 2 quarters · filed 2024-11-14 | $774.74K 10-Q · filed 2024-11-14 | $1.06M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $289.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $579.98K 10-Q · filed 2024-08-14 | $869.70K derived: sum of 3 quarters · filed 2024-08-14 | $1.16M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $290.31K 10-Q · filed 2024-05-15 | $580.03K derived: sum of 2 quarters · filed 2024-05-15 | $869.75K derived: sum of 3 quarters · filed 2024-05-15 | $1.16M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $289.72K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $579.44K derived: sum of 2 quarters · filed 2024-04-01 | $866.28K derived: sum of 3 quarters · filed 2024-04-01 | $1.20M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $289.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $576.56K derived: sum of 2 quarters · filed 2023-11-14 | $913.25K 10-Q · filed 2023-11-14 | $1.23M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $286.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $623.53K 10-Q · filed 2023-08-14 | $940.43K derived: sum of 3 quarters · filed 2023-08-14 | $1.45M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $336.69K 10-Q · filed 2023-05-15 | $653.59K derived: sum of 2 quarters · filed 2023-05-15 | $1.16M derived: sum of 3 quarters · filed 2023-05-15 | $1.63M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $316.91K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $823.55K derived: sum of 2 quarters · filed 2023-03-31 | $1.29M derived: sum of 3 quarters · filed 2023-03-31 | $1.72M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $506.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $976.26K derived: sum of 2 quarters · filed 2022-11-10 | $1.41M 10-Q · filed 2022-11-10 | $1.77M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $469.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $900.29K 10-Q · filed 2022-08-12 | $1.26M derived: sum of 3 quarters · filed 2022-08-12 | $1.63M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $430.68K 10-Q · filed 2022-05-13 | $793.63K derived: sum of 2 quarters · filed 2022-05-13 | $1.16M derived: sum of 3 quarters · filed 2022-05-13 | $1.48M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $362.95K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $727.96K derived: sum of 2 quarters · filed 2022-03-03 | $1.05M derived: sum of 3 quarters · filed 2022-03-03 | $1.29M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $365.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $688.23K derived: sum of 2 quarters · filed 2021-11-12 | $930.44K 10-Q · filed 2021-11-12 | $1.12M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $323.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $565.43K 10-Q · filed 2021-08-13 | $755.75K derived: sum of 3 quarters · filed 2021-08-13 | $928.67K derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | $242.21K 10-Q · filed 2021-05-13 | $432.53K derived: sum of 2 quarters · filed 2021-05-13 | $605.44K derived: sum of 3 quarters · filed 2021-05-13 | $675.29K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $190.32K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $363.24K derived: sum of 2 quarters · filed 2021-02-12 | $433.08K derived: sum of 3 quarters · filed 2021-02-12 | $477.10K 10-K · filed 2021-02-12 | |
| 2019-09-30 | $172.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $242.76K derived: sum of 2 quarters · filed 2020-11-12 | $286.78K 10-Q · filed 2020-11-12 | $338.29K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $69.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $113.86K 10-Q · filed 2020-08-10 | $165.38K derived: sum of 3 quarters · filed 2020-08-10 | ||
| 2019-03-31 | $44.02K 10-Q · filed 2020-05-15 | $95.53K derived: sum of 2 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $51.52K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $110.24K 10-K · filed 2020-03-12 | |||
| 2018-09-30 | $58.72K 10-Q · filed 2019-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |